Tang Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-90,215
| Closed | -$8.4M | – | 5 |
|
|
2017
Q3 | $8.4M | Hold |
90,215
| – | – | 2.56% | 4 |
|
|
2017
Q2 | $8.19M | Hold |
90,215
| – | – | 2.91% | 4 |
|
|
2017
Q1 | $7.92M | Hold |
90,215
| – | – | 2.86% | 4 |
|
|
2016
Q4 | $7.47M | Hold |
90,215
| – | – | 3.99% | 5 |
|
|
2016
Q3 | $8.35M | Hold |
90,215
| – | – | 3.46% | 5 |
|
|
2016
Q2 | $7.02M | Hold |
90,215
| – | – | 3.13% | 5 |
|
|
2016
Q1 | $7.44M | Hold |
90,215
| – | – | 3.39% | 4 |
|
|
2015
Q4 | $9.45M | Sell |
90,215
-92,085
| -51% | -$9.65M | 3.75% | 4 |
|
|
2015
Q3 | $19.2M | Hold |
182,300
| – | – | 7.08% | 4 |
|
|
2015
Q2 | $24.9M | Hold |
182,300
| – | – | 7.57% | 5 |
|
|
2015
Q1 | $22.7M | Hold |
182,300
| – | – | 12.08% | 4 |
|
|
2014
Q4 | $16.5M | Hold |
182,300
| – | – | 9.04% | 5 |
|
|
2014
Q3 | $13.2M | Hold |
182,300
| – | – | 6.82% | 6 |
|
|
2014
Q2 | $11.3M | Hold |
182,300
| – | – | 5.25% | 6 |
|
|
2014
Q1 | $12.4M | Hold |
182,300
| – | – | 6.03% | 6 |
|
|
2013
Q4 | $12.8M | Hold |
182,300
| – | – | 8.97% | 5 |
|
|
2013
Q3 | $13.2M | Hold |
182,300
| – | – | 6.52% | 8 |
|
|
2013
Q2 | $10.2M | Buy |
+182,300
| New | +$10.2M | 4% | 10 |
|